Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients - Related Studies

Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients

This study has been completed.

Study NCT00097942. Last updated on February 14, 2006. Information provided by Forest Laboratories

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Schizophrenia

2	More general conditions related to this trial
		Mental Disorders
		Schizophrenia and Disorders with Psychotic Features

3	Interventions listed in this trial
		memantine HCl

4	Additional drug interventions recognized in this trial
		Memantine

5	More general drug interventions related to this trial
		Anti-Dyskinesia Agents
		Antiparkinson Agents
		Central Nervous System Agents
		Dopamine Agents
		Excitatory Amino Acid Agents
		Excitatory Amino Acid Antagonists
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Forest Laboratories